Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ponnuraja

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The Indian Journal of Tuberculosis|March 20, 2014
HIV-infected patients retreated for tuberculosis with intermittent Category II regimen--treatment outcome at 24-month follow-upRamesh Kumar, Pradeep A Menon, C Ponnuraja, et al.
International Journal of Mycobacteriology|January 21, 2016
Quality indicators in a mycobacteriology laboratory supporting clinical trials for pulmonary tuberculosisN Selvakumar, K Silambuchelvi, M Gomathi Sekar, et al.
The Indian Journal of Medical Research|February 28, 2009
Sensitivity & specificity of combination testing algorithms for HIV in a tuberculosis clinicSoumya Swaminathan, L Antony, P Venkatesan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2022
Heightened Microbial Translocation Is a Prognostic Biomarker of Recurrent TuberculosisNathella Pavan Kumar, Kadar Moideen, Vijay Viswanathan, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 30, 2012
Assessment of panel slides prepared by phenol ammonium sulphate and NALC methods for proficiency testingR Radhakrishnan, M M P Kumar, S Prabuseenivasan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 15, 2013
Early changes in hepatic function among HIV-tuberculosis patients treated with nevirapine or efavirenz along with rifampin-based anti-tuberculosis therapyC Padmapriyadarsini, P K Bhavani, Alice Tang, et al.
Plos One|May 5, 2012
The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysisMai T Pho, Soumya Swaminathan, Nagalingeswaran Kumarasamy, et al.
The Indian Journal of Tuberculosis|March 1, 2025
Pharmacokinetic drug-drug interaction between first-line anti-TB and anti-diabetic drugs in patients with tuberculosis and diabetes mellitusMary Rebecca Yowaraj, Sudha Vilvamani, T Bharathiraja, et al.
Scientific Reports|January 14, 2021
Discovery of a highly potent novel rifampicin analog by preparing a hybrid of the precursors of the antibiotic drugs rifampicin and clofaziminePasupathy Saravanan, V N Azger Dusthackeer, R S Rajmani, et al.
The Indian Journal of Tuberculosis|March 21, 2020
Effectiveness and safety of bedaquiline under conditional access program for treatment of drug-resistant tuberculosis in India: An interim analysisV S Salhotra, K S Sachdeva, Neelima Kshirsagar, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Indian Journal of Tuberculosis|March 20, 2014
HIV-infected patients retreated for tuberculosis with intermittent Category II regimen--treatment outcome at 24-month follow-upRamesh Kumar, Pradeep A Menon, C Ponnuraja, et al.
International Journal of Mycobacteriology|January 21, 2016
Quality indicators in a mycobacteriology laboratory supporting clinical trials for pulmonary tuberculosisN Selvakumar, K Silambuchelvi, M Gomathi Sekar, et al.
The Indian Journal of Medical Research|February 28, 2009
Sensitivity & specificity of combination testing algorithms for HIV in a tuberculosis clinicSoumya Swaminathan, L Antony, P Venkatesan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2022
Heightened Microbial Translocation Is a Prognostic Biomarker of Recurrent TuberculosisNathella Pavan Kumar, Kadar Moideen, Vijay Viswanathan, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 30, 2012
Assessment of panel slides prepared by phenol ammonium sulphate and NALC methods for proficiency testingR Radhakrishnan, M M P Kumar, S Prabuseenivasan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 15, 2013
Early changes in hepatic function among HIV-tuberculosis patients treated with nevirapine or efavirenz along with rifampin-based anti-tuberculosis therapyC Padmapriyadarsini, P K Bhavani, Alice Tang, et al.
Plos One|May 5, 2012
The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysisMai T Pho, Soumya Swaminathan, Nagalingeswaran Kumarasamy, et al.
The Indian Journal of Tuberculosis|March 1, 2025
Pharmacokinetic drug-drug interaction between first-line anti-TB and anti-diabetic drugs in patients with tuberculosis and diabetes mellitusMary Rebecca Yowaraj, Sudha Vilvamani, T Bharathiraja, et al.
Scientific Reports|January 14, 2021
Discovery of a highly potent novel rifampicin analog by preparing a hybrid of the precursors of the antibiotic drugs rifampicin and clofaziminePasupathy Saravanan, V N Azger Dusthackeer, R S Rajmani, et al.
The Indian Journal of Tuberculosis|March 21, 2020
Effectiveness and safety of bedaquiline under conditional access program for treatment of drug-resistant tuberculosis in India: An interim analysisV S Salhotra, K S Sachdeva, Neelima Kshirsagar, et al.
Pageof 3